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Diagnostic accuracyWe compared the Vitek MS and Microﬂex MALDI-TOF mass spectrometry platform for species differentiation
within the Streptococcus mitis group with PCR assays targeted at lytA, Spn9802, and recA as reference standard.
The Vitek MS correctly identiﬁed 10/11 Streptococcus pneumoniae, 13/13 Streptococcus pseudopneumoniae,
and 12/13 S. mitis/oralis. The Microﬂex correctly identiﬁed 9/11 S. pneumoniae, 0/13 S. pseudopneumoniae, and
13/13 S. mitis/oralis. MALDI-TOF is a powerful tool for species determination within the mitis group. Diagnostic
accuracy varies depending on platform and database used.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).It is clinically relevant to distinguish Streptococcus pneumoniae from
other less virulent, members of the viridans group streptococci (VGS).
Accurate species determination within the VGS and more speciﬁcally
within the mitis subgroup is traditionally difﬁcult. To overcome this
problem, PCR assays targeting virulence genes and fragments, such as
the autolysin gene (lytA), the pneumolysin gene (ply), and the
Spn9802 DNA fragment, have been designed. However, also
nonpneumococcal species of the VGS may harbor lytA and ply
(Whatmore et al., 2000), thereby affecting the speciﬁcity of these assays.
Sequence analysis of the 16S rRNA gene also has limited discriminatory
power within the VGS, as Streptococcus mitis, Streptococcus oralis, and S.
pneumoniae exhibit more than 99% sequence homology (Kawamura
et al., 1995). Matrix-assisted laser desorption ionization–time-of-ﬂight
(MALDI-TOF) mass spectrometry shows promising results for differen-
tiation of species within the mitis group (Angeletti et al., 2015), but
further exploration and validation are needed. To complicate the
diagnostic challenges within the VGS, in 2004, a new species within
the VGS that closely resembles S. pneumoniae was described and
designated as Streptococcus pseudopneumoniae. To this end, a real-time
PCR assay for the speciﬁc detection of S. pseudopneumoniae has been
developed (Zbinden et al., 2011; Sistek et al., 2012). To gain further
insight in the clinical relevance of S. pseudopneumoniae, it is important
to have accurate diagnostic methods available.is is an open access article under the CCWe evaluated the ability of 2 MALDI-TOF mass spectrometry plat-
forms for species differentiation within the mitis subgroup. A panel
consisting of 29 clinical and 8 reference isolates was tested with both
the Biotyper and Vitek MS MALDI-TOF mass spectrometry platforms.
The reference strains used included 2 S. pneumoniae (ATCC 6305 and
ATCC 49619), 2 S. pseudopneumoniae (CCUG 48465 and CCUG 49455),
2 S. mitis (LMG 14552 and LMG 14557), and 2 S. oralis (LMG 14532 of
14533). As a gold standard,we combined real-time PCR assays targeting
lytA, recA, and Spn9802, which were adapted from methods described
by Sistek et al. (2012), Carvalho Mda et al. (2007), and Suzuki et al.
(2005). The assays were performed as described by Wessels et al.
(2012). Instead of 50-μL reactions, 10-μL 0.5 McFarland solution was
added to 15-μL PCR mix, resulting in 25-μL reactions. No DNA isolation
was performed. The PCR assays targeting the lytA and recA genes are
speciﬁc for S. pneumoniae and S. pseudopneumoniae, respectively. The
PCR assay targeting the Spn9802 fragment detects both S. pneumoniae
and S. pseudopneumoniae but no other VGS. Hence, strains that tested
negative in all 3 PCR assays were designated S.mitis/oralis.
MALDI-TOFmass spectrometry with the Microﬂex platform (Bruker
Daltonics, Bremen, Germany) was performed as previously described
(van Veen et al., 2010). Single colonies were transferred in duplicate
onto a target plate and overlaid with matrix solution. FlexControl soft-
ware (version 3.4) was used for measurements. The spectra were ana-
lyzed using BioTyper software (version 3.1.66; Bruker) and database
MBT DB-5627. An identiﬁcation score of ≥2.0 was considered a reliable
genus and species identiﬁcation. Results that indicated S. oralis,
S. mitis, or other (nonpneumococcus or pseudopneumococcus) speciesBY license (http://creativecommons.org/licenses/by/4.0/).
Table 2
The sensitivity and speciﬁcity of the 2 MALDI-TOF systems.
S. pneumoniae S. pseudopneumoniae S. mitis/oralis
TP
(n)
FP
(n)
Sens Spec TP
(n)
FP
(n)
Sens Spec TP
(n)
FP
(n)
Sens Spec
Vitek MS 10 0 91% 100% 13 0 100% 100% 12 1 92% 96%
Microﬂex 9 3 82% 83% 0 0 0% 100% 13 2 100% 86%
Real-time
PCR
11 n/
a
n/a n/a 13 n/
a
n/a n/a 13 n/
a
n/a n/a
TP = true positives; FN = false negatives; Sens = sensitivity; Spec = speciﬁcity; n/
a = not applicable.
The numbers of true positives, false negatives, sensitivity, and speciﬁcity of the 2 MALDI-
TOF systems for detection of different species of the mitis group streptococci are shown.
For PCR, no false positives, sensitivity, and speciﬁcity are calculated as PCR (targeted at
Spn9802, lytA, and recA) was the reference standard.
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analysis. Discordant results of the ﬁrst best match and second best
match or inconsistency of the duplicate determination (unless both in
the S.mitis/oralis group) were classiﬁed as an ambiguous result.
Mass spectrometry with the Vitek MS platform (bioMérieux, Marcy
l’Etiole, France) was performed using the following software and data-
base: VitekMS ACQ 1.4.2b, VitekMS Prep 2.3.3, and Myla 3.2.0. Single
colonieswere transferred onto a target plate, and a singlemeasurement
was performed. An identiﬁcation score of ≥95% was considered to be a
reliable identiﬁcation at the species level. If no identiﬁcation could be
assigned, a second run was performed. If this second run also failed
to assign a species, then the strain was regarded as unidentiﬁed
for analysis.
The results of the determinations with real-time PCR, the Vitek MS,
and the Microﬂex platform are shown in Table 1. In total, the panel in-
cluded 11 pneumococci, 13 pseudopneumococci, and 13 S. mitis/oralis.
The sensitivity and speciﬁcity of the 2MALDI-TOF systems for detection
of the separate species are shown in Table 2. Using the Vitek MS plat-
form, 1 S.mitis/oralis strain could not be identiﬁed, and 1 S. pneumoniae
strain was incorrectly identiﬁed as S.mitis/oralis group. All other strains
were identiﬁed correctly. Using theMicroﬂex platform, all S.mitis/oralis
and 9 of the 11 S. pneumoniae in the panel were correctly identiﬁed.
However, none of the S. pseudopneumoniae in the panel was correctly
identiﬁed.
We found that mass spectrometry has the ability to adequately dis-
tinguish relevant species within the mitis group streptococci. However,
we observed that the Microﬂex platform could not differentiate
between pneumococci and pseudopneumococci, whereas the Vitek
MS platform could. This is likely attributable to the use of different
databases and/or different determination algorithms. The database
used by the Microﬂex platform contains 30 S. pneumoniae isolates and
only 1 S. pseudopneumoniae isolate. The Microﬂex platform matches
the spectrometry pattern of the isolates tested to the pattern of a best
matching single isolate pattern (multiple reference isolates of most
species are in the database), whereas the Vitek MS platform matches
the spectrometry pattern to a composite pattern of a species (which is
composed ofmultiple patterns of several reference isolates of a species).
Difference in mass resolution between the mass spectrometers may
also be of relevance: the Vitek MS has a larger tube and possibly more
detailed spectra and thereby more accuracy might be obtained.
This could be evaluated further using larger Biotyper platforms.
Althoughwe report on a relative small sample size, we actually have
one of the largest numbers of pseudopneumococci studied by mass
spectrometry (Angeletti et al., 2015; Werno et al., 2012). Indeed, other
groups have studied MALDI-TOF determination of larger streptococci
panels, but theses panels included far less S. pseudopneumoniae
(Dubois et al., 2013). Other recent studies that compared MALDI-TOF
platforms did not speciﬁcally focus on the mitis group (Martiny et al.,
2012; Deak et al., 2015). Furthermore, to our knowledge, our study is
only the second study that investigates a direct comparison between 2
MALDI-TOF platforms for discrimination between pneumococci and
pseudopneumococci (Angeletti et al., 2015). Despite the small numberTable 1
Distribution of determinations with real-time PCR, the Vitek MS, and the Microﬂex
platform.
n Real-time PCR Vitek MS Microﬂex
8 S. pneumoniae S. pneumoniae S. pneumoniae
2 S. pneumoniae S. pneumoniae Ambiguous
1 S. pneumoniae S. mitis/oralis S. pneumoniae
3 S. pseudopneumoniae S. pseudopneumoniae S. pneumoniae
2 S. pseudopneumoniae S. pseudopneumoniae S. mitis/oralis
7 S. pseudopneumoniae S. pseudopneumoniae Ambiguous
1 S. pseudopneumoniae S. pseudopneumoniae No ID
12 S. mitis/oralis S. mitis/oralis S. mitis/oralis
1 S. mitis/oralis No ID S. mitis/oralisof isolates, we feel that our study highlights differences in diagnostic ac-
curacy between different MALDI-TOF platforms and databases for par-
ticular bacterial species. It is of interest that Angeletti et al. (2015)
recently published a paper with similar results in which the Microﬂex
never identiﬁed S. pseudopneumoniae. However, in their study, only 2
of 17 pseudopneumococci were identiﬁed by the Vitek MS. This
difference most likely can be explained by the use of different
database or software version, although the use of a different molecular
reference standard (rpoB gene sequencing) or clonal differences in
S. pseudopneumoniae strains used may also play a role.
In conclusion,mass spectrometry can be a powerful tool for bacterial
species determination within the mitis group streptococci. Clinical
microbiologist and researchers should be aware that different MALDI-
TOF platforms rely on different databases and algorithms for species de-
termination and that subsequent differences in diagnostic accuracy
seem to exist. Continuous improvement and evaluation of mass spec-
trometry databases are recommended.
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